Open access · CC-BY
via OpenAlex
Impact of Rapamycin on Longevity: Updated Insights
Mehdi Sanati, Amir R. Afshari, Samaneh Aminyavari, Maciej Banach, Amirhossein Sahebkar
Archives of Medical Science · 2024 · ▲ 3 citations
Deregulated nutrient-sensing
Rapamycin / mTOR inhibition
Cell culture / in vitro
Human
Preclinical / animal
In vitro
Review
Abstract
The gradual accumulation of varying detrimental alterations during the aging process within cells and tissues contributes to a progressive decline in their functionality, which may ultimately result in death. The licensed mTOR(definition) inhibitor, rapamycin(definition), also known as sirolimus, has recently become a promising option for anti-aging applications. Through in vitro and in vivo assessments, numerous scientific reports have illustrated diverse biochemical and clinical aspects of rapamycin's pharmacological effects in ameliorating aging-related changes and expanding longevity. Nevertheless, its clinical application has been impeded by severe adverse effects, which might be addressed by implementing an appropriate therapeutic regimen. In this regard, integrating updated insights and uncovering essential benefits and drawbacks of rapamycin as a geroprotective drug is critical for conducting further preclinical research and well-organized clinical trials and moving toward the clinic. This review highlighted recent findings on the role of rapamycin in improving organ health and postponing aging-related processes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.5114/aoms/191565
- Canonical
- link ↗
- Fetched
- 2026-11-06 MST
Cite this
APA
Sanati, M., Afshari, A.R., Aminyavari, S., Banach, M., & Sahebkar, A. (2024). Impact of Rapamycin on Longevity: Updated Insights. <em>Archives of Medical Science</em>. https://doi.org/10.5114/aoms/191565
Vancouver
Sanati M, Afshari AR, Aminyavari S, Banach M, Sahebkar A. Impact of Rapamycin on Longevity: Updated Insights. Archives of Medical Science. 2024. doi:10.5114/aoms/191565.
BibTeX
@article{mehdi2024Impact,
title = {Impact of Rapamycin on Longevity: Updated Insights},
author = {Mehdi Sanati and Amir R. Afshari and Samaneh Aminyavari and Maciej Banach and Amirhossein Sahebkar},
journal = {Archives of Medical Science},
year = {2024},
doi = {10.5114/aoms/191565},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Veterinary Science 2025
Open access · CC-BY
A review of rapamycin in companion dogs
Cardiology in Review 2025
Citation only
Taurine and Berberine: Nutritional Interventions Targeting Cellular Mechanisms of Aging and Longevity
Cureus 2025
Open access · CC-BY
The Mechanistic Target of Rapamycin (mTOR) Pathway as a Target of Anti-aging Therapies: The Role of Rapamycin and Its Analogs in the Regulation of Cellular Processes and Their Impact on Longevity
Cureus 2025
Open access · OA
The Mechanistic Target of Rapamycin (mTOR) Pathway as a Target of Anti-aging Therapies: The Role of Rapamycin and Its Analogs in the Regulation of Cellular Processes and Their Impact on Longevity.
Translational Medicine of Aging 2020
Open access · CC-BY
RTB101 and immune function in the elderly: Interpreting an unsuccessful clinical trial
JK Science 2026
Open access · CC-BY